Legend Biotech
Manufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2101 Cottontail Ln, Somerset, New Jersey...Phone Number
(732) 317-5050Website
www.legendbiotech.comRevenue
$627.2 MillionStock Symbol
LEGNIndustry
About Legend Biotech
Legend Biotech Org Chart
Is Legend Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Legend Biotech is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Legend Biotech launches new products
Funding: Get notified immidiatlly once Legend Biotech has new funding data
Congratulate Masked Content for being promoted to Masked Content at Legend Biotech
Legend Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Legend Biotech had a recent Job posting/layoffs
Earning: See what the market has to say on Legend Biotech recently announced quarterly report
Check if Legend Biotech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Legend Biotech
Compare insights from companies similar to Legend Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Legend Biotech
Company Profile Activity
Activity Insights
Legend Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Legend Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Legend Biotech.
Legend Biotech financials insights
Gather financial insights about Legend Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$150.5M
Stock Offering
$424M
Legend Biotech Tech Stack
A closer look at the technologies used by Legend Biotech
Most Recent Scoops
Legend Biotech News & Media
Legend Biotech Announces CEO Transition
BRIDGEWATER, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced that Ying Huang, Ph.D., has stepped down as Chief Executive Officer and as a member of the Board of Directors, effective as of July 24, 2026. Dr. Huang will remain as an advisor through August to support a smooth transition.Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Legend Biotech Corporation (NASDAQ:LEGN) is among the best healthcare stocks. TheFly reported on June 3 that UBS increased its price target on LEGN to $49 from $31 while reiterating a Buy rating on the stock. The firm cited […]Legend Biotech Corporation Announces Pricing of Public Offering
BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSsLegend Biotech Corporation Announces Proposed Public Offering
BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced that it has commenced an underwritten public offering of $225 million of American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company. All of the ADSs will be offered by Legend Biotech. Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Legend Biotech
Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.... Read More
